Department of General Surgery, Affiliated Shuyang Peoples' Hospital, Xuzhou Medical University, Xuzhou, Jiangsu, China (mainland).
Department of Neurology, Affiliated Shuyang Peoples' Hospital, Xuzhou Medical University, Xuzhou, Jiangsu, China (mainland).
Med Sci Monit. 2018 Jun 9;24:3888-3894. doi: 10.12659/MSM.907922.
BACKGROUND Systemic inflammatory response syndrome (SIRS) is characterized by systemic inflammation and tissue injury. Secondary sepsis is a common critical illness associated with poor clinical outcome. The aim of this study was to investigate the risk of SIRS-positive and SIRS-negative sepsis following gastrointestinal (GI) perforation. MATERIAL AND METHODS A retrospective study included 51 patients with GI perforation who had clinical evidence of sepsis, with or without SIRS. Clinical outcome was assessed at day 30 using the Glasgow Outcome Scale (GOS) (score, 1-5) and the sequential organ failure assessment (SOFA) (score, 1-6) to determine organ function. RESULTS Fifty-one patients were included in the study (median age, 74 years; 37 male patients); 20 patients (39.2%) developed secondary sepsis; 16 patients (80%) had SIRS-negative sepsis; four patients had SIRS-positive sepsis. An increased SOFA score was a significant independent predictor of GI perforation with sepsis (5.4±3.1 vs. 1.5±2.8) (P<0.0001). Patients with GI perforation with SIRS-negative sepsis had a significantly less favorable outcome (5/16 vs. 2/35) (P=0.03). The risk of SIRS-negative sepsis following GI perforation was 39.2%, and the risk of mortality for SIRS-negative sepsis was 31.3%. In the Cox regression analysis, septic shock and septic encephalopathy were associated with a worse clinical outcome. CONCLUSIONS The findings of this study support the recognition of SIRS-negative sepsis following GI perforation as an important condition to recognize clinically, given its association with increased patient morbidity and mortality.
全身炎症反应综合征(SIRS)的特征是全身炎症和组织损伤。继发性脓毒症是一种常见的危重病,与不良临床结局相关。本研究旨在探讨胃肠道(GI)穿孔后 SIRS 阳性和 SIRS 阴性脓毒症的风险。
本回顾性研究纳入了 51 例有脓毒症临床证据的 GI 穿孔患者,包括有或无 SIRS。使用格拉斯哥预后评分(GOS)(评分 1-5)和序贯器官衰竭评估(SOFA)(评分 1-6)在第 30 天评估临床结局,以确定器官功能。
本研究纳入了 51 例患者(中位年龄 74 岁;男性 37 例);20 例(39.2%)患者发生继发性脓毒症;16 例(80%)患者为 SIRS 阴性脓毒症;4 例患者为 SIRS 阳性脓毒症。SOFA 评分升高是伴有脓毒症的 GI 穿孔的显著独立预测因素(5.4±3.1 与 1.5±2.8)(P<0.0001)。伴有 SIRS 阴性脓毒症的 GI 穿孔患者的结局明显较差(5/16 与 2/35)(P=0.03)。GI 穿孔后发生 SIRS 阴性脓毒症的风险为 39.2%,SIRS 阴性脓毒症的死亡率为 31.3%。在 Cox 回归分析中,感染性休克和感染性脑病与较差的临床结局相关。
本研究结果支持将 GI 穿孔后 SIRS 阴性脓毒症视为一种重要的临床情况,因为它与患者发病率和死亡率的增加相关。